US 8592456
IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8592456 (IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation) held by 4SC DISCOVERY GMBH expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- 4SC DISCOVERY GMBH
- Grant date
- Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/14, A61P17/00